Medical Information
United States
 

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

Información selecta para pacientes y cuidadores que se encuentra disponible en Español.

This content is intended for U.S. Healthcare Professionals. Would you like to proceed?

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

dobutamine in 5% dextrose injection, USP Principal Display Panel

PRINCIPAL DISPLAY PANEL - 250 mL Bag - 2,000 mcg/mL

250 mL
NDC 0409-2347-31

DOBUTamine
in 5% Dextrose Injection, USP
500 mg/250 mL
(2,000 mcg/mL)

EACH 100 mL CONTAINS DOBUTAMINE
HYDROCHLORIDE EQUIVALENT TO
200 mg OF DOBUTAMINE; DEXTROSE,
HYDROUS 5 g; WITH SODIUM
METABISULFITE 25 mg AND EDETATE
DISODIUM DIHYDRATE 10 mg ADDED
AS STABILIZERS. 270 mOsmol/LITER
(CALC.). pH 3.0 (2.5 TO 5.5). MAY
CONTAIN HYDROCHLORIC ACID
AND/OR SODIUM HYDROXIDE FOR pH
ADJUSTMENT. FOR INTRAVENOUS
USE. USUAL DOSAGE: SEE INSERT.
WARNING: CONTAINS SULFITES

DRUG ADDITIVES SHOULD NOT BE
MADE TO THIS SOLUTION.

STERILE, NONPYROGENIC. USE
ONLY IF SOLUTION IS CLEAR AND
CONTAINER IS UNDAMAGED. MUST
NOT BE USED IN SERIES
CONNECTIONS.

7
OTHER

RX ONLY

IM-5129

DISTRIBUTED BY
HOSPIRA, INC., LAKE FOREST, IL 60045 USA
Hospira

PRINCIPAL DISPLAY PANEL - 250 mL Bag - 2,000 mcg/mL

PRINCIPAL DISPLAY PANEL - 250 mL Bag Overwrap - 2,000 mcg/mL

TO OPEN — TEAR AT NOTCH

250 mL
NDC 0409-2347-31

DOBUTamine
in 5% Dextrose Injection, USP
500 mg/250 mL
(2,000 mcg/mL)

Each 100 mL contains Dobutamine Hydrochloride equivalent to 200 mg of
dobutamine; dextrose, hydrous 5 g; with sodium metabisulfite 25 mg and
edetate disodium dihydrate 10 mg added as stabilizers.
WARNING: CONTAINS SULFITES

270 mOsmol/liter (calc.).
pH 3.0 (2.5 to 5.5).

May contain hydrochloric acid and/or sodium hydroxide for pH
adjustment. For intravenous use. Usual dosage: see insert.

Single-dose container

Drug additives should not be made to this solution. The overwrap is a
moisture and oxygen barrier. Do not remove unit from overwrap until
ready for use. Visually inspect overwrap for tears or holes. Discard unit
if overwrap is damaged. The solution may exhibit a pink color, but no
significant loss in potency has occurred. Use unit promptly when
overwrap is opened. Store at 20 to 25°C (68 to 77°F). [See USP Controlled
Room Temperature.] Protect from freezing. See insert. After removing
the overwrap, check for minute leaks by squeezing container firmly. If
leaks are found, discard solution as sterility may be impaired.

Rx only

7
OTHER

MADE IN ITALY
F WR-1529

Distributed by Hospira, Inc., Lake Forest, IL 60045 USA
Hospira

PRINCIPAL DISPLAY PANEL - 250 mL Bag Overwrap - 2,000 mcg/mL

PRINCIPAL DISPLAY PANEL - 250 mL Bag - 1,000 mcg/mL

250 mL
NDC 0409-2346-31

DOBUTamine
in 5% Dextrose Injection, USP
250 mg/250 mL
(1,000 mcg/mL)

EACH 100 mL CONTAINS DOBUTAMINE
HYDROCHLORIDE EQUIVALENT TO
100 mg OF DOBUTAMINE;
DEXTROSE, HYDROUS 5 g; WITH
SODIUM METABISULFITE 25 mg AND
EDETATE DISODIUM DIHYDRATE
10 mg ADDED AS STABILIZERS.
263 mOsmol/LITER (CALC.). pH 3.0
(2.5 TO 5.5). MAY CONTAIN
HYDROCHLORIC ACID AND/OR
SODIUM HYDROXIDE FOR pH
ADJUSTMENT. FOR INTRAVENOUS
USE. USUAL DOSAGE: SEE INSERT.
WARNING: CONTAINS SULFITES

DRUG ADDITIVES SHOULD NOT BE
MADE TO THIS SOLUTION.

STERILE, NONPYROGENIC. USE
ONLY IF SOLUTION IS CLEAR AND
CONTAINER IS UNDAMAGED. MUST
NOT BE USED IN SERIES
CONNECTIONS.

RX ONLY

7
OTHER

IM-5130

DISTRIBUTED BY
HOSPIRA, INC., LAKE FOREST, IL 60045 USA
Hospira

PRINCIPAL DISPLAY PANEL - 250 mL Bag - 1,000 mcg/mL

PRINCIPAL DISPLAY PANEL - 250 mL Bag Overwrap - 1,000 mcg/mL

TO OPEN — TEAR AT NOTCH

250 mL
NDC 0409-2346-31

DOBUTamine
in 5% Dextrose Injection, USP

250 mg/250 mL
(1,000 mcg/mL)

Each 100 mL contains Dobutamine Hydrochloride equivalent to 100 mg of
dobutamine; dextrose, hydrous 5 g; with sodium metabisulfite 25 mg and
edetate disodium dihydrate 10 mg added as stabilizers.

WARNING: CONTAINS SULFITES

263 mOsmol/liter (calc.).
pH 3.0 (2.5 to 5.5).

May contain hydrochloric acid and/or sodium hydroxide for pH
adjustment. For intravenous use. Usual dosage: see insert.

Single-dose container

Drug additives should not be made to this solution. The overwrap is a
moisture and oxygen barrier. Do not remove unit from overwrap until
ready for use. Visually inspect overwrap for tears or holes. Discard unit
if overwrap is damaged. The solution may exhibit a pink color, but no
significant loss in potency has occurred. Use unit promptly when
overwrap is opened. Store at 20 to 25°C (68 to 77°F). [See USP Controlled
Room Temperature.] Protect from freezing. See insert. After removing
the overwrap, check for minute leaks by squeezing container firmly.
If leaks are found, discard solution as sterility may be impaired.

7
OTHER

Rx only

MADE IN ITALY
F WR-1528

Distributed by Hospira, Inc., Lake Forest, IL 60045 USA
Hospira

PRINCIPAL DISPLAY PANEL - 250 mL Bag Overwrap - 1,000 mcg/mL

PRINCIPAL DISPLAY PANEL - 250 mL Bag - 4,000 mcg/mL

250 mL
NDC 0409-3724-11

DOBUTamine
in 5% Dextrose Injection, USP
1,000 mg/250 mL
(4,000 mcg/mL)

EACH 100 mL CONTAINS DOBUTAMINE
HYDROCHLORIDE EQUIVALENT TO 400 mg
OF DOBUTAMINE; DEXTROSE, HYDROUS
5 g; WITH SODIUM METABISULFITE 25mg
AND EDETATE DISODIUM DIHYDRATE
10 mg ADDED AS STABILIZERS.
284 mOsmol/LITER (CALC.). pH 3.0 (2.5 TO
5.5). MAY CONTAIN HYDROCHLORIC ACID
AND/OR SODIUM HYDROXIDE FOR pH
ADJUSTMENT. FOR INTRAVENOUS USE.
USUAL DOSAGE: SEE INSERT.
WARNING: CONTAINS SULFITES

DRUG ADDITIVES SHOULD NOT BE
MADE TO THIS SOLUTION.

STERILE, NONPYROGENIC. USE ONLY IF
SOLUTION IS CLEAR AND CONTAINER IS
UNDAMAGED. MUST NOT BE USED IN
SERIES CONNECTIONS.

RX ONLY

7
OTHER

IM-5128

DISTRIBUTED BY
HOSPIRA, INC., LAKE FOREST, IL 60045 USA
Hospira

PRINCIPAL DISPLAY PANEL - 250 mL Bag - 4,000 mcg/mL

PRINCIPAL DISPLAY PANEL - 250 mL Bag Overwrap - 4,000 mcg/mL

TO OPEN — TEAR AT NOTCH

250 mL
NDC 0409-3724-11

DOBUTamine
in 5% Dextrose Injection, USP

1,000 mg/250 mL
(4,000 mcg/mL)

Each 100 mL contains Dobutamine Hydrochloride equivalent to 400 mg of
dobutamine; dextrose, hydrous 5 g; with sodium metabisulfite 25 mg
and edetate disodium dihydrate 10 mg added as stabilizers.
WARNING: CONTAINS SULFITES

284 mOsmol/liter (calc.).
pH 3.0 (2.5 to 5.5).

May contain hydrochloric acid and/or sodium hydroxide for pH
adjustment. For intravenous use. Usual dosage: see insert.

Single-dose container

Drug additives should not be made to this solution. The overwrap is a
moisture and oxygen barrier. Do not remove unit from overwrap until
ready for use. Visually inspect overwrap for tears or holes. Discard unit
if overwrap is damaged. The solution may exhibit a pink color, but no
significant loss in potency has occurred. Use unit promptly when
overwrap is opened. Store at 20 to 25°C (68 to 77°F). [See USP Controlled
Room Temperature.] Protect from freezing. See insert. After removing
the overwrap, check for minute leaks by squeezing container firmly.
If leaks are found, discard solution as sterility may be impaired.

Rx only

7
OTHER

MADE IN ITALY
F WR-1530

Distributed by Hospira, Inc., Lake Forest, IL 60045 USA
Hospira

PRINCIPAL DISPLAY PANEL - 250 mL Bag Overwrap - 4,000 mcg/mL
Did you find an answer to your question? Yes No
Didn’t find what you were looking for? Contact us.
Report Adverse Event